Conversely, women with untreated or unclear treatment status regarding their diagnosis of endometriosis were considered in two studies,21, 24 directly and indirectly comparing ultralong GnRH agonists, long GnRH agonists, and progestins for CPR and PLR, showing that both progestins (OR 0.28 [95% CI 0.10–0.78]) and ultralong GnRH agonists (OR 0.18 [95% CI 0.05–0.67]) were less efficacious than long GnRH agonists for increasing the CPR (Figure S8a–d), also confirmed best treatment in SUCRA analysis (SUCRA 99.0%). This evidence concerns the gene GNRH1 and endometriosis.